National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
| Autor: | Vladimir Hachinski, Costantino Iadecola, Ron C. Petersen, Monique M. Breteler, David L. Nyenhuis, Sandra E. Black, William J. Powers, Charles DeCarli, Jose G. Merino, Raj N. Kalaria, Harry V. Vinters, David M. Holtzman, Gary A. Rosenberg, Anders Wallin, Martin Dichgans, John R. Marler, Gabrielle G. Leblanc |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Advanced and Specialized Nursing
medicine.medical_specialty business.industry Cognitive disorder Neuropsychology Brain Cognition Neuropsychological Tests Binswanger's disease medicine.disease Magnetic Resonance Imaging Cerebrovascular Disorders Physical medicine and rehabilitation medicine Humans Dementia Neurology (clinical) Alzheimer's disease Cognition Disorders Cardiology and Cardiovascular Medicine Psychiatry Vascular dementia business Stroke |
| Zdroj: | Stroke. 37:2220-2241 |
| ISSN: | 1524-4628 0039-2499 |
| DOI: | 10.1161/01.str.0000237236.88823.47 |
| Popis: | Background and Purpose— One in 3 individuals will experience a stroke, dementia or both. Moreover, twice as many individuals will have cognitive impairment short of dementia as either stroke or dementia. The commonly used stroke scales do not measure cognition, while dementia criteria focus on the late stages of cognitive impairment, and are heavily biased toward the diagnosis of Alzheimer disease. No commonly agreed standards exist for identifying and describing individuals with cognitive impairment, particularly in the early stages, and especially with cognitive impairment related to vascular factors, or vascular cognitive impairment. Methods— The National Institute for Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) convened researchers in clinical diagnosis, epidemiology, neuropsychology, brain imaging, neuropathology, experimental models, biomarkers, genetics, and clinical trials to recommend minimum, common, clinical and research standards for the description and study of vascular cognitive impairment. Results— The results of these discussions are reported herein. Conclusions— The development of common standards represents a first step in a process of use, validation and refinement. Using the same standards will help identify individuals in the early stages of cognitive impairment, will make studies comparable, and by integrating knowledge, will accelerate the pace of progress. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|